Krystal, J. H., Abdallah, C. G., Sanacora, G., Charney, D. S., & Duman, R. S. | Neuron | 6 March 2019
Investigation of medical effect of multiple ketamine infusions on patients with major depressive disorder
Zheng, W., Zhou, Y. L., Liu, W. J., Wang, C. Y., Zhan, Y. N., Li, H. Q., & Ning, Y. P. | Journal of Psychopharmacology | 21 February 2019
Neurochemical models of near-death experiences: A large-scale study based on the semantic similarity of written reports.
Martial, C., Cassol, H., Charland-Verville, V., Pallavicini, C., Sanz, C., Zamberlan, F., ... & Tagliazucchi, E. | Consciousness and cognition | 1 February 2019
Effects of Ketamine on Brain Activity During Emotional Processing: Differential Findings in Depressed Versus Healthy Control Participants.
Reed, J. L., Nugent, A. C., Furey, M. L., Szczepanik, J. E., Evans, J. W., & Zarate Jr, C. A. | Biological Psychiatry: Cognitive Neuroscience and Neuroimaging | 25 January 2019
Neurochemical models of near-death experiences: A large-scalestudy based on the semantic similarity of written reports
Martial, C., Cassol, H., Charland-Verville, V., Pallavicini, C., Sanz, C., Zamberlan, F., & Tagliazucchi, E. | Consciousness and cognition | 20 January 2019
Association of Combined Naltrexone and Ketamine With Depressive Symptoms in a Case series of Patients With Depression and Alcohol Use Disorder
Yoon, G., Petrakis, I. L., & Krystal, J. H. | JAMA psychiatry | 9 January 2019
Dadiomov, D., & Lee, K. | Mental Health Clinician | 4 January 2019
Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment‐resistant depression
Salloum, N. C., Fava, M., Freeman, M. P., Flynn, M., Hoeppner, B., Hock, R. S., & Mathew, S. J. | Depression and anxiety | 30 December 2018
Ketamine interactions with gut-microbiota in rats: relevance to its antidepressant and anti-inflammatory properties.
Getachew, B., Aubee, J. I., Schottenfeld, R. S., Csoka, A. B., Thompson, K. M., & Tizabi, Y. | BMC microbiology | 22 December 2018
Cullen, K. R., Amatya, P., Roback, M. G., Albott, C. S., Westlund Schreiner, M., Ren, Y., ... & Reigstad, K. | Journal of child and adolescent psychopharmacology | 1 November 2018
Hirota, K. and Lambert, D. | British Journal of Anaesthesia | 12 October 2018 |
Neurocognitive effects of six ketamine infusions and the association with antidepressant response in patients with unipolar and bipolar depression
Zhou, Y., Zheng, W., Liu, W., Wang, C., Zhan, Y., Li, H., & Ning, Y.| Journal of Psychopharmacology | 27 September 2018
Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial.
Ionescu, D. F., Bentley, K. H., Eikermann, M., Taylor, N., Johnson-Akeju, O., Swee, M. B., ... & Alpert, J. E. | Journal of Affective Disorders | 17 September 2018
Rapid effectiveness of intravenous ketamine for ultraresistant depression in a clinical setting and evidence for baseline anhedonia and bipolarity as clinical predictors of effectiveness
Thomas, R. K., Baker, G., Lind, J., & Dursun, S. | Journal of psychopharmacology | 5 September 2018
Jones, J. L., Mateus, C. F., Malcolm, R. J., Brady, K. T., & Back, S. E. | Frontiers in Psychiatry | 24 July 2018
Riva-Posse, P., Reiff, C. M., Edwards, J. A., Job, G. P., Galendez, G. C., Garlow, S. J., ... & McDonald, W. M. | Journal of affective disorders | 19 July 2018
Reed, J. L., Nugent, A. C., Furey, M. L., Szczepanik, J. E., Evans, J. W., & Zarate Jr, C. A. | NeuroImage: Clinical | 5 July 2018
Schenberg, E. E. S. | Frontiers in pharmacology | 5 July 2018
Bartova, L., Papageorgiou, K., Milenkovic, I., Dold, M., Weidenauer, A., Willeit, M., ... & Kasper, S. | European Neuropsychopharmacology | 2 July 2018
Pharmacological fMRI: Effects of subanesthetic ketamine on resting-state functional connectivity in the default mode network, salience network, dorsal attention network and executive control network.
Mueller, F., Musso, F., London, M., de Boer, P., Zacharias, N., & Winterer, G. | NeuroImage: Clinical | 1 June 2018
Duman, R. S. | F1000Research | 24 May 2018
Ketamine Effects on EEG during Therapy of Treatment-Resistant Generalized Anxiety and Social Anxiety
Shadli, S. M., Kawe, T., Martin, D., McNaughton, N., Neehoff, S., & Glue, P. | International Journal of Neuropsychopharmacology | 24 April 2018
Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder
Rong, C., Park, C., Rosenblat, J. D., Subramaniapillai, M., Zuckerman, H., Fus, D., ... & Cha, D. S. | International journal of environmental research and public health | 17 April 2018
Ketamine for the treatment of major depressive disorder and bipolar depression: A review of the literature
Grady, S. E., Marsh, T. A., Tenhouse, A., & Klein, K. | Mental Health Clinician | 23 March 2018
Repeated intranasal ketamine for treatment-resistant depression – the way to go? Results from a pilot randomised controlled trial
Gálvez, V., Li, A., Huggins, C., Glue, P., Martin, D., Somogyi, A. A., ... & Loo, C. K. | Journal of Psychopharmacology | 15 March 2018